The 'biogeneric' analysis problem The 'biogeneric' analysis problem 07-Jun-2007 By Dr Matt Wilkinson The apparent inability of current analytical techniques to fully characterise complex biological drugs still stands in the way of easy approval pathways for 'biogenerics' or copies of off-patent brand name biologics.